Effectiveness of moxibustion treatment as adjunctive therapy in osteoarthritis of the knee: a randomized, double-blinded, placebo-controlled clinical trial

Table 1 Participant demographic and baseline characteristics $\bar{x} \pm s$

Characteristics	Active group	Sham group	Total
Characteristics	(n = 55)	(n = 55)	(n = 110)
Age, years	65.80 ± 7.45	64.55 ± 8.38	65.17 ± 7.89
Gender, n (%)
Male	16 (29.09)	21 (38.18)	37 (33.63)
Female	39 (70.90)	34 (61.81)	73 (66.36)
Target knees, n (%)
1 knee	12 (21.82)	18 (32.73)	30 (27.27)
Both knees	43 (78.18)	37 (67.27)	80 (72.72)
Length of osteoarthritis diagnosis, n (%)
<5 years	30 (54.55)	37 (67.27)	67 (60.90)
6-10 years	18 (32.73)	12 (21.82)	30 (27.27)
>10 years	7 (12.73)	6 (1.090)	13 (11.82)
Weight, kg	64.06 ± 9.02	66.01 ± 5.21	65.04 ± 6.33
Height, cm	1.63 ± 5.28	1.62 ± 1.45	1.62 ± 7. 98
Body mass index	24.11 ± 1.08	25.15 ± 2.41	24.63 ± 5.52
Outcomes (baseline)
WOMAC pain score	6.73 ± 2.35	6.29 ± 2.70	6.51 ± 2.53
WOMAC function score	33.47.0 ± 15.37	30.99 ± 17.82	32.23 ± 16.61

There were no differences between the groups in age, gender, course of disease, or condition of the diseased knee (P >0.05). There were no differences between the groups in Western Ontario and McMaster Universities’ Osteoarthritis Index (WOMAC) pain or physical function scores (P >0.05).

ISSN: 1478-6362